GL1X · GenesisL1 explorer

MolNFT v1 · #184359 · protein

PARP1 catalytic domain in complex with isoquinolone-based inhibitor (compound 16)

7ONS · Poly [ADP-ribose] polymerase 1: “PARP1 catalytic domain in complex with isoquinolone-based inhibitor (compound 16)”. X-ray diffraction, 2 ligands (VKT, SO4), 10 pockets (best druggability 0.79). MolNFT v1 #184359 on GenesisL1: 3D…

PDB
7ONS
Type
protein
Length
698 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 1
EC
2.4.2.30, 2.4.2.-
UniProt
P09874
Ligands
VKT, SO4
Pockets
10 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APoly [ADP-ribose] polymerase 1 (EC 2.4.2.30, 2.4.2.-)protein35040% helix, 25% strandP09874
BPoly [ADP-ribose] polymerase 1 (EC 2.4.2.30, 2.4.2.-)protein34840% helix, 23% strandP09874

Ligands and binding sites

  • VKT · 7-[[4-(1,5-dimethylimidazol-2-yl)piperazin-1-yl]methyl]-3-ethyl-1~{H}-quinolin-2-one · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 5 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13690.790.8836VKT
23930.770.8741VKT
34800.710.8148SO4
4530.480.8613empty
51260.470.7830empty

Interfaces

1 interface between chains.

  • A–B · 829 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 7ONS · PARP1 catalytic domain in complex with isoquinolone-based inhibitor (compound 16) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.